Zinzino AB (publ) reported revenue results for the month and year to date ended April 2026. For the month, the company reported Zinzino's sales markets increased by 22 % and amounted to SEK 300.8 million (SEK 246.6) million. Faun Pharma's external sales decreased and amounted to SEK 4.6 million (SEK 6.1) million. Overall, the Group increased revenues by 21 % to SEK 305.4 million (SEK 252.7) million compared with the previous year.

For year to date, the company reported revenue for January - April 2026 increased by 26 % to SEK 1,227.5 million (SEK 976.3 million).